Evidence map›Paper›PMID 28759651›Full record

ArticlePLoS pathogens2017

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Gustavo H Kijak, Eric Sanders-Buell, Agnes-Laurence Chenine, Michael A Eller, Nilu Goonetilleke, Rasmi Thomas, Sivan Leviyang, Elizabeth A Harbolick, Meera Bose, Phuc Pham and 30 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 11 institutions in 4 countries.

Gustavo H KijakU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0002-2746-9533
Eric Sanders-BuellU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Agnes-Laurence ChenineU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Michael A EllerU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0003-3905-4877
Nilu GoonetillekeSchool of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Rasmi ThomasU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Sivan LeviyangDepartment of Mathematics and Statistics, Georgetown University, Washington, DC, United States of America.ORCID http://orcid.org/0000-0002-8315-3146
Elizabeth A HarbolickU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Meera BoseU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Phuc PhamU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Celina OropezaU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Kultida PoltaveeU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Anne Marie O'SullivanU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Erik BillingsU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0002-8963-0484
Melanie MerbahU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0002-5641-8612
Margaret C CostanzoU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Joanna A WarrenSchool of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Bonnie SlikeU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Hui LiPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Kristina K PeachmanU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Will FischerTheoretical Biology, Los Alamos National Laboratory, Los Alamos, NM, United States of America.ORCID http://orcid.org/0000-0003-4579-4062
Feng GaoDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
Claudia CicalaLaboratory of Immunoregulation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
James ArthosLaboratory of Immunoregulation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Leigh A EllerU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0003-2043-1513
Robert J O'ConnellArmed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Samuel SineiWalter Reed Project, Kericho, Kenya.
Lucas MagangaMbeya Medical Research Programme, Mbeya, Tanzania.
Hannah KibuukaMakerere University-Walter Reed Project, Kampala, Uganda.ORCID http://orcid.org/0000-0002-2293-1944
Sorachai NitayaphanArmed Forces Research Institute of Medical Sciences, Bangkok, Thailand.ORCID http://orcid.org/0000-0001-6935-1405
Mangala RaoU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Mary A MarovichVaccine Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Shelly J KrebsU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Morgane RollandU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Bette T KorberTheoretical Biology, Los Alamos National Laboratory, Los Alamos, NM, United States of America.ORCID http://orcid.org/0000-0002-2026-5757
George M ShawPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Nelson L MichaelU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0001-5882-5548
Merlin L RobbU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0003-3949-9649
Sodsai TovanabutraU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0002-5946-4227
Jerome H KimU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.ORCID http://orcid.org/0000-0003-0461-6438
Henry M. Jackson Foundation · USNational Institutes of Health · USWalter Reed Army Institute of Research · USArmed Forces Research Institute of Medical Science · THLos Alamos National Laboratory · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USDuke Medical Center · USGeorgetown University · USMakerere University Walter Reed Project · UGMbeya University of Science and Technology · TZ

Funding

Virus and Antibody Gene Sequencing CoreP01AI131251 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Kevin Wiehe · 2017 to 2026
$40.7M
Role of HIV Envelope Proteins In Viral Replication and HIV PathogenesisZIAAI000887 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CICALA, CLAUDIA · 2009 to 2025
$15.2M
Interaction of HIV envelope with cell surface receptorsZIAAI000883 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ARTHOS, JAMES L · 2009 to 2024
$14.0M
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccinesR01AI118549 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHAW, GEORGE M · 2016 to 2020
$3.6M
NIAID NIH HHS P01 AI131251NIAID NIH HHS R01 AI118549
6 · The paper itself

Abstract

In order to inform the rational design of HIV-1 preventive and cure interventions it is critical to understand the events occurring during acute HIV-1 infection (AHI). Using viral deep sequencing on six participants from the early capture acute infection RV217 cohort, we have studied HIV-1 evolution in plasma collected twice weekly during the first weeks following the advent of viremia. The analysis of infections established by multiple transmitted/founder (T/F) viruses revealed novel viral profiles that included: a) the low-level persistence of minor T/F variants, b) the rapid replacement of the major T/F by a minor T/F, and c) an initial expansion of the minor T/F followed by a quick collapse of the same minor T/F to low frequency. In most participants, cytotoxic T-lymphocyte (CTL) escape was first detected at the end of peak viremia downslope, proceeded at higher rates than previously measured in HIV-1 infection, and usually occurred through the exploration of multiple mutational pathways within an epitope. The rapid emergence of CTL escape variants suggests a strong and early CTL response. Minor T/F viral strains can contribute to rapid and varied profiles of HIV-1 quasispecies evolution during AHI. Overall, our results demonstrate that early, deep, and frequent sampling is needed to investigate viral/host interaction during AHI, which could help identify prerequisites for prevention and cure of HIV-1 infection.

Indexed as

AdolescentAdultCohort StudiesFemaleHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansImmune EvasionMaleMiddle AgedT-Lymphocytes, CytotoxicYoung Adult

Identifiers

PMID28759651
PMCPMC5552316
OpenAlexW2742086727

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.